CCL8



CCL8

Q1QQ1P2PP2D3DD3S4SS4V5VV5S6SS6I7II7P8PP8I9II9T10TT10C11CC11C12CC12F13FF13N14NN14V15VV15I16II16N17NN17R18RR18K19KK19I20II20P21PP21I22II22Q23QQ23R24RR24L25LL25E26EE26S27SS27Y28YY28T29TT29R30RR30I31II31T32TT32N33NN33I34II34Q35QQ35C36CC36P37PP37K38KK38E39EE39A40AA40V41VV41I42II42F43FF43K44KK44T45TT45K46KK46R47RR47... and 29 more residue(s)...... and 29 more residue(s)

SMILES None
InChIKey None
Sequence QPDSVSIPITCCFNVINRKIPIQRLESYTRITNIQCPKEAVIFKTKRGKEVCADPKERWVRDSMKHLDQIFQNLKP

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


Bioactivities

CCL8

Q1QQ1P2PP2D3DD3S4SS4V5VV5S6SS6I7II7P8PP8I9II9T10TT10C11CC11C12CC12F13FF13N14NN14V15VV15I16II16N17NN17R18RR18K19KK19I20II20P21PP21I22II22Q23QQ23R24RR24L25LL25E26EE26S27SS27Y28YY28T29TT29R30RR30I31II31T32TT32N33NN33I34II34Q35QQ35C36CC36P37PP37K38KK38E39EE39A40AA40V41VV41I42II42F43FF43K44KK44T45TT45K46KK46R47RR47... and 29 more residue(s)...... and 29 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.